Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aquestive Therapeutics Inc
(NQ:
AQST
)
5.670
+0.050 (+0.89%)
Official Closing Price
Updated: 7:55 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Aquestive Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
71 Biggest Movers From Friday
February 24, 2019
Gainers Achieve Life Sciences, Inc. (NASDAQ: ACHV) shares surged 82.32 percent to close at $3.30 on Friday after the company ...
Tags
ROKU
NCMI
ANIK
From
Benzinga
Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights on March 14, 2019
February 19, 2019
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that it...
From
PR Newswire
Aquestive Therapeutics to Present at 2019 BIO CEO & Investor Conference
February 08, 2019
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company, focused on developing and commercializing differentiated products to solve therapeutic problems today announced that...
From
PR Newswire
Aquestive Therapeutics Provides Update Regarding Suboxone® Sublingual Film Litigation
February 05, 2019
Aquestive Therapeutics, Inc. (Nasdaq: AQST), a specialty pharmaceutical company, focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that...
From
PR Newswire
64 Biggest Movers From Yesterday
January 31, 2019
Gainers Fortress Biotech (NASDAQ: FBIO) shares gained 39.86 percent to close at $2.07 after the company highlighted a ...
Tags
CMPR
IIVI
ACIU
From
Benzinga
48 Stocks Moving In Thursday's Mid-Day Session
January 31, 2019
Gainers Fortress Biotech (NASDAQ: FBIO) shares climbed 48.6 percent to $2.20 after the company highlighted a collaboration ...
Tags
WDAY
AQST
NMCI
From
Benzinga
Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.'s Apomorphine Sublingual Film (APL-130277) New Drug Application
January 31, 2019
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, learned today its...
From
PR Newswire
31 Stocks Moving In Thursday's Pre-Market Session
January 31, 2019
Gainers Fortress Biotech, Inc. (NASDAQ: FBIO) shares rose 94 percent to $2.87 in pre-market trading after the company reported ...
Tags
HRB
MDC
TI
From
Benzinga
62 Biggest Movers From Yesterday
January 30, 2019
Gainers Co-Diagnostics Inc (NASDAQ: CODX) jumped 101.8 percent to close at $2.24 on Wednesday after the company announced the sale ...
Tags
DGLY
SLAB
SALT
From
Benzinga
48 Stocks Moving In Wednesday's Mid-Day Session
January 30, 2019
Gainers Co-Diagnostics Inc (NASDAQ: CODX) jumped 209.5 percent to $3.4355 after the company announced the sale of 3 million ...
Tags
T
OCX
SYK
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive
January 28, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ...
Tags
Trading Ideas
IBB
Offerings
From
Benzinga
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
January 27, 2019
Biotech stocks came under modest selling pressure in the shortened trading week, which saw the release of earnings by some large-cap ...
Tags
Benzinga
SRDX
SXTC
From
Benzinga
Aquestive Therapeutics Granted Temporary Restraining Order (TRO) Against Alvogen
January 25, 2019
Aquestive Therapeutics, Inc. (Nasdaq: AQST), a specialty pharmaceutical company, focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that...
From
PR Newswire
55 Biggest Movers From Yesterday
January 22, 2019
Gainers Avalon GloboCare Corp. (NASDAQ: AVCO) shares jumped 124.11 percent to close at $12.55 on Tuesday. Luokung Technology ...
Tags
LEU
GOGL
Top Gainers
From
Benzinga
52 Biggest Movers From Friday
January 21, 2019
Gainers Moxian, Inc. (NASDAQ: MOXC) shares jumped 86.87 percent to close at $0.7101 on Friday after the company announced a ...
Tags
JBHT
Markets
CRON
From
Benzinga
Aquestive Therapeutics Appoints Gary H. Slatko, M.D. as Chief Medical Officer
January 03, 2019
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to solve therapeutic problems, today...
From
PR Newswire
Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates
December 31, 2018
After a strong 2017, biotech stocks are on track to end the year in the red despite a record 59 new molecular entity approvals, some ...
Tags
FDA
ACOR
Fluzone Quadrivalent
From
Benzinga
50 Biggest Movers From Yesterday
December 27, 2018
Gainers BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares climbed 80.91 percent to close at $4.36 on Thursday after the ...
Tags
KOD
HX
LUNA
From
Benzinga
Analysts Expect IWN Will Reach $138
December 24, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Aquestive Therapeutics Provides End of Year Business Update, Including Progress of its Proprietary CNS Assets, Financial and Legal Matters
December 19, 2018
- Projects full year 2018 revenues over $67 million, exceeding expectations, and projects end-of-year cash and cash equivalents in the range of $58 million to $60 million
From
PR Newswire
The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
December 18, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week highs ...
Tags
SNSS
BTAI
GERN
From
Benzinga
Aquestive Therapeutics Schedules Business Update Conference Call on December 20, 2018
December 18, 2018
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to solve therapeutic problems, today...
From
PR Newswire
The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan
December 18, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ...
Tags
EVGN
ARDX
DARE
From
Benzinga
Aquestive Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
December 07, 2018
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today...
From
PR Newswire
60 Biggest Movers From Yesterday
December 06, 2018
Gainers Ferrellgas Partners, L.P. (NYSE: FGP) jumped 68.42 percent to close at $1.28 on Thursday after the company beat Q1 sales ...
Tags
Pre/Market Outlook
News
GIII
From
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
December 06, 2018
Gainers Uxin Limited (NASDAQ: UXIN) shares jumped 32 percent to $3.7743 after the company announced a strategic partnership with ...
Tags
AWSM
MNTX
SIG
From
Benzinga
The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering
December 05, 2018
Here's a roundup of top developments in the biotech space over the past 48 hours. Scaling The Peak (Biotech stocks hitting ...
Tags
CLSD
CRIS
SHPG
From
Benzinga
Aquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with Epilepsy
December 03, 2018
-- Studies show DBF, tentatively named Libervant™, was successfully administered and had similar bioavailability whether given during/immediately following a seizure or between seizures
From
PR Newswire
Aquestive Therapeutics Launches SYMPAZAN™ (clobazam) Oral Film with Widespread U.S. Availability
November 29, 2018
Establishes extensive Authorized Distributor Network to ensure easy access through retail pharmacies nationwide and mail order
From
PR Newswire
The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved
November 29, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ...
Tags
RSLS
FDA
Offerings
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.